Lupus Type Anticoagulant  (LUP ANTI)
|
Synonyms:
| Lupus Anticoagulant; Lupus Anticoagulant Screen |
Specimen: | Blood; (1) Blue (sodium citrate) top vacutainer tube.
Patient preparation: Avoid warfarin (Coumadin®) therapy for two weeks and heparin therapy for two days prior to the test.
|
Volume: | Full primary tube |
Minimum Volume: | 2 mL plasma |
Collection: | Citrated plasma samples should be collected by double centrifugation. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap, and recentrifuge for 10 minutes. Use a second plastic pipette to transfer plasma to a plastic purple screw-capped aliquot tube and freeze.
Specimen must remain frozen until tested. |
Rejection Criteria: | Hemolysis; clotted specimen; specimen contaminated with heparin; specimen received unfrozen: improper labeling. |
Reference Range: | See report |
Methodology: | PTT-LA (lupus-senstive APTT) and DRVVT screen, mixing study if screening tests are prolonged; confiramtion if the mixing study does not coorelate. |
Test Use: | The qulaitative detection of lupus anticoaulants in plasma |
Additional Information: | Patient preparation: Avoid warfarin (Coumadin) therapy for 2 weeks and heparin therapy for 2 days prior to the test. If reflex testing is performed, additional charges/CPT code9s) may apply |
Testing Includes: | Specimen sent to LabCorp. LabCorp test # 117892.
Qualitative detection of lupus anticoagulants. |
Testing Facility: | LabCorp |